The Cfr methyltransferase confers resistance to many 50S ribosomal subunit-targeted antibiotics, including linezolid (LZD), via methylation of the 23S rRNA base A2503 in the peptidyl transferase center. Methicillin-resistant Staphylococcus aureus strain CM05 is the first clinical isolate documented to carry cfr. While cfr is typically plasmid borne, in CM05 it is located on the chromosome and is coexpressed with ermB as part of the mlr operon. Here we evaluated the chromosomal locus, association with mobile genetic elements, and stability of the cfr insertion region in CM05. The cfr-containing mlr operon is located within a 15.5-kb plasmid-like insertion into 23S rRNA allele 4. The region surrounding the cfr gene has a high degree of sequence similarity to the broad-host-range toxin/antitoxin multidrug resistance plasmid pSM19035, including a second ermB gene downstream of the mlr locus and istAS-istBS. Analysis of several individual CM05 colonies revealed two distinct populations for which LZD MICs were either 8 or 2 g/ml. In the LZD s colonies (designated CM05⌬), a recombination event involving the two ermB genes had occurred, resulting in the deletion of cfr and the 3= flanking region (cfr-istAS-istBS-ermB). The fitness advantage of CM05⌬ over CM05 (though not likely due to the cfr deletion itself) results in the predominance of CM05⌬ in the absence of selective pressure. Minicircles resulting from the ermB recombination event and the novel association of cfr with the pSM19035 plasmid system support the potential for the continued dissemination of cfr. R esistance to linezolid (LZD) was reported shortly after its introduction into the clinic and included both staphylococcal and enterococcal strains carrying G2576T mutations in one or more alleles of the domain V-encoding region of 23S rRNA genes (21, 57). These mutations perturb the conformation of the peptidyl transferase center, which is the target of oxazolidinones in the 50S ribosomal subunit (30, 52, 59 ). More recently, LZD resistance has been linked to additional mutations identified in the genes encoding 50S ribosomal proteins L3 and L4 (34, 58). Most problematic has been the identification of cfr, a horizontally transferable gene encoding a ribosomal methyltransferase that confers resistance to multiple classes of antibacterial agents targeting the peptidyl transferase center by posttranscriptional modification of the 23S rRNA (29). Recent studies have shown that Cfr methylates carbon 8 of nucleotide A2503 (20), thereby conferring a PhLOPS A phenotype characterized by decreased binding of phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A class antibiotics (29, 37, 56) , as well as of 16-membered ring macrolides (55), to Cfr-methylated ribosomes. Of further concern is the low fitness cost associated with Cfr methylation (31) and the documentation of clinical cfr strains possessing co-occurring mutations in 23S rRNA (14) and ribosomal proteins L3 (36) and L4 (5). The need to maintain potency against strains with cfr and/or other LZD resistance determinants has supported the development of expanded-spectrum oxazolidinones, such as TR-700, which retains MIC activity in the presence of Cfr methylation (33) and also has greater potency than LZD against strains possessing ribosomal structural mutations (34-36).
R
esistance to linezolid (LZD) was reported shortly after its introduction into the clinic and included both staphylococcal and enterococcal strains carrying G2576T mutations in one or more alleles of the domain V-encoding region of 23S rRNA genes (21, 57) . These mutations perturb the conformation of the peptidyl transferase center, which is the target of oxazolidinones in the 50S ribosomal subunit (30, 52, 59 ). More recently, LZD resistance has been linked to additional mutations identified in the genes encoding 50S ribosomal proteins L3 and L4 (34, 58) . Most problematic has been the identification of cfr, a horizontally transferable gene encoding a ribosomal methyltransferase that confers resistance to multiple classes of antibacterial agents targeting the peptidyl transferase center by posttranscriptional modification of the 23S rRNA (29) . Recent studies have shown that Cfr methylates carbon 8 of nucleotide A2503 (20) , thereby conferring a PhLOPS A phenotype characterized by decreased binding of phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A class antibiotics (29, 37, 56) , as well as of 16-membered ring macrolides (55) , to Cfr-methylated ribosomes. Of further concern is the low fitness cost associated with Cfr methylation (31) and the documentation of clinical cfr strains possessing co-occurring mutations in 23S rRNA (14) and ribosomal proteins L3 (36) and L4 (5) . The need to maintain potency against strains with cfr and/or other LZD resistance determinants has supported the development of expanded-spectrum oxazolidinones, such as TR-700, which retains MIC activity in the presence of Cfr methylation (33) and also has greater potency than LZD against strains possessing ribosomal structural mutations (34) (35) (36) .
The cfr gene was originally identified on the pSCSF1 plasmid from Staphylococcus sciuri, isolated from the nasal swab of a florfenicol-treated calf with a respiratory infection (Bavaria, Germany, 1997) (28, 51) . The gene was later found in several staphylococcal veterinary isolates from swine (Staphylococcus aureus, Staphylococcus lentus) and cattle (Staphylococcus simulans, S. aureus) on both pSCFS3 and pSCFS1 (28) . It was also detected among florfenicol-resistant porcine-derived staphylococci from Denmark on pSCSF6, isolated from Staphylococcus warneri and S. simulans, and in the chromosome of Staphylococcus hyicus isolates (26) . A recent report from China identified a cfr-positive Bacillus isolate from swine feces (16) . The first clinical isolate documented to carry the cfr gene was a methicillin-resistant Staphylococcus aureus (MRSA) strain from a patient in Medellin, Colombia (2005) , who had received two doses of linezolid (56) . In this isolate, designated CM05, the presence of the cfr gene was demonstrated to be associated with oxazolidinone resistance (56) . Subsequently, additional LZD-resistant (LZD r ) clinical staphylococci (S. aureus and coagulase-negative staphylococci [CoNS] ) of diverse geographical origins (Arizona, Ohio, Belgium, Italy, Spain, Mexico, and Ireland) have been shown to carry the cfr gene (5, 7, 14, 17, 19, 23, 24, (39) (40) (41) (42) (43) 53) . Approximately one-quarter of the cfr-positive isolates described in these reports are S. aureus, and the remainder are CoNS, largely Staphylococcus epidermidis. Recently, the first clinical cfr-positive enterococci (Enterococcus faecium and Enterococcus faecalis) were characterized and were shown to possess G2576T 23S rRNA mutations in addition to cfr (14) . The cfr gene is typically monocistronic, associated with transposons, and plasmid borne, which presumably can result in ready exchange between Gram-positive strains (27, 29) .
In the initial CM05 cfr locus study, the sequence of a 5.8-kb fragment containing the cfr gene was determined, and Southern blotting was utilized to document that this gene was chromo-somally located (56) , rather than being present on the 33.7-kb pCM05 plasmid (GenBank accession no. GQ900387). The cfr gene in CM05 was located downstream of the ermB ribosomal methyltransferase gene, and both genes were shown to be constitutively coexpressed in the mlr operon (55) . However, the total size, sequence, and chromosomal locus of the cfr insertion in the CM05 chromosome were unknown, as was the stability of cfr in this strain. Here we identify the region surrounding the cfr gene, elucidate the chromosomal site of insertion, and evaluate the stability of the cfr locus in MRSA CM05.
(Portions of this work were presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy [36a] , San Francisco, CA, 12 to 15 September 2009.)
MATERIALS AND METHODS
Bacterial strains and culture conditions. S. aureus strains CM05, CM05⌬, and ATCC 29213 were cultured aerobically at 37°C on cationadjusted Mueller-Hinton II agar (MHA; Becton Dickinson, Franklin Lakes, NJ) or in Mueller-Hinton II broth (MHB). CFU were enumerated by serially diluting bacteria in phosphate-buffered saline (PBS) and plating on MHA.
Antimicrobial agents. Solutions of TR-700 (tedizolid, formerly known as torezolid; Trius Therapeutics, Inc., San Diego, CA), LZD (ChemPacific Corp., Baltimore, MD), vancomycin (VAN; Sigma-Aldrich Corp., St. Louis, MO), chloramphenicol (CHL; Sigma), erythromycin (ERY; Sigma), and tiamulin (TIA; Wako Pure Chemical Industries, Ltd., Richmond, VA) were prepared fresh prior to use in MIC assays or selective media.
MIC testing. MIC assays were performed via broth microdilution in accordance with CLSI guidelines (15) , and values were determined visually through detection with alamarBlue (Invitrogen Corp., Carlsbad, CA) as described previously (3) . MIC assays were repeated at least 3 times, independently, with identical results.
PCR and genome sequencing. Sequencing of the CM05 genome was performed by pyrosequencing at the University of Illinois at UrbanaChampaign (49) . Single-primer PCR (25) was used to elucidate the chromosomal sequences upstream and downstream of cfr. Targeted PCR (Platinum PCR SuperMix High Fidelity; Invitrogen) and primer extension sequencing (Retrogen, Inc., San Diego, CA) were used for elucidation of the chromosomal integration site of cfr and for the assembly of some contigs resulting from problems with automated assembly spanning repeated sequences. rRNA rrn alleles 1, 3, 4, and 5 were amplified by PCR using previously described primers (44) . Allele 2 was amplified with primers rrn6_RF (reverse complement to rrn6_R [38, 46] ) and rrn2_R (44) , and allele 6 was amplified using 16S_F (Table 1 ) and rrn6_R (38, 46) . Sequence data were assembled using Vector NTI Advance 11 software (Invitrogen) and were annotated based on homology to sequence data from NCBI BLAST analyses (2) . A list of primers used to amplify and sequence the cfr insertion region is provided in Table 1 .
CM05 population analysis of variation in LZD susceptibility. A master glycerol stock sample of CM05 was grown to an optical density at 600 nm (OD 600 ) of 0.30 in MHB and was then diluted to ϳ6.5 ϫ 10 2 CFU/ml, and 100-l aliquots were spread on MHA plates containing different concentrations of LZD (0.25, 0.5, 1, 2, 4, 8, 16, or 32 g/ml) or TR-700 (0.25, 0.5, 1, or 2 g/ml) or no drug. Following overnight growth, CFU were enumerated, and the plating efficiencies of CM05 on the two drugs were compared.
Serial passage of CM05 under nonselective conditions. A clonal cfrpositive CM05 culture was grown overnight in MHB. The following day, the culture was diluted 1:1,000 in MHB to start the subsequent cycle. Passaging was repeated for 75 days, and the ratio of LZD s to LZD r colonies was determined every 5th passage by streaking a sample onto MHA, picking 96 colonies, placing them in a 96-well plate with MHB, and then stamping them into a plate containing MHB plus 4 g/ml LZD. Once cfr-positive colonies were under the level of detection by plating, the totalpopulation DNA was isolated from each subsequent passage and was PCR amplified for the presence of the cfr gene using cfr_F/cfr_R (Table 1) .
Serial passage of a CM05-CM05⌬ mixture in the presence of LZD and TR-700. The initial CM05 glycerol stock (mixture of CM05 and CM05⌬) was serially passaged on MHA plates with continuous antibiotic gradients (6) containing LZD (0.0 to 8 g/ml) or TR-700 (0.0 to 4 g/ml) as described previously (35) . A glycerol stock was made from each passage for subsequent MIC and sequence analyses of individual colonies. Follow- ing 30 serial passages, total-population MICs were determined with cells recovered from both TR-700 and LZD passage conditions. Growth curves. Three individual CM05 and CM05⌬ colonies were cultured on MHA plus 4 g/ml LZD or on MHA alone, respectively. The following day, multiple colonies from each plate were resuspended in MHB, and levels were adjusted to an OD 600 of 0.30. Cultures were then diluted 1:100 into test tubes containing 3 ml MHB. OD 600 values were recorded every 2 h for 24 h. An unpaired, 2-tailed t test was used to compare OD 600 values for CM05 and CM05⌬ at each time point.
Nucleotide sequence accession number. The cfr-containing 15,511-bp insertion region sequence, as well as partial flanking 23S rRNA gene sequences, has been deposited in the NCBI database under GenBank accession no. JN849634. The deposited sequence extends 5= and 3= from the partial repS and istAS genes, respectively, previously deposited for CM05 (GenBank accession no. EF450709) (56) .
RESULTS
The 15.5-kb plasmid-like cfr insertion region disrupts 23S rRNA allele 4. Analysis of the CM05 pyrosequencing data did not identify the insertion site of the previously characterized mlr locus, so single-primer PCR was used to sequence the flanking region extending outward from the 5= and 3= ends of mlr (repS and istBS, respectively). The resulting sequencing data from the istBS flanking sequence identified genes consistent with those of the multidrug resistance plasmid pSM19035 (ermB, zeta, epsilon, omega, delta, gamma, beta, alpha) (4). Reanalysis of the assembled wholegenome pyrosequencing data revealed a contig containing an alpha gene sequence flanking a portion of a 23S rRNA allele. To determine which 23S allele was disrupted, each of the six rrn rRNA operons was amplified using template DNA isolated from S. aureus CM05 in addition to ATCC 29213, which was used as a reference. PCR amplicons of the predicted sizes were obtained for all six alleles in ATCC 29213 and for five of the six alleles in CM05 (allele 4 [rrlD] did not generate a PCR band) (Fig. 1) . To confirm the integration of the cfr plasmid-like region in rrlD, inwardfacing PCR primers binding the external flanking genes (i.e., the first non-rRNA or tRNA genes) MW1986 and ilvA (derived from the S. aureus MW2 genome sequence; GenBank accession no. NC_003923) were paired with outward-facing cfr plasmid region primers (MW1986_F/repS_F and ilvA_F/alpha_R, respectively) ( Table 1 ). The resulting amplicons were sequenced, which confirmed specific 15,511-bp integration in 23S rRNA allele 4 between nucleotides 1256 and 1257 of the 2,923-bp gene (flanking sequences shown as GTTGAAGCAT on the left side of Fig. 2A and GATCGTAAGG on the right side). A 233-bp deletion was detected between 5S rRNA allele 4 and ilvA, resulting in a truncated ilvA gene (data not shown).
The associated cfr insertion region has high similarity to the broad-host-range plasmid pSM19035. BlastN analysis of the 15.5-kb insert demonstrated that nearly 60% of the sequence is identical to regions of pSM19035 (GenBank accession no. NC_006979), a low-copy-number plasmid with a broad host range in Gram-positive bacteria, including Bacillus subtilis, Streptococcus pyogenes, and S. aureus (4, (10) (11) (12) (13) 18) . This high degree of similarity extends from CM05 insert nucleotides 1 to 2218, which include the pSM19035 plasmid origin of replication oriR, the repS gene, involved in the initiation of plasmid replication (22) , and a truncated version of the copy number control gene copS, all of which are in the reverse orientation relative to the published CM05 cfr gene ( Fig. 2A) (56) .
As shown in a previous CM05 study (56) , the mlr operon lies in the opposite orientation to repS and encodes resistance to macrolides, lincosamides, and streptogramin B class antibiotics (due to expression of the ermB ribosomal methyltransferase modifying 23S rRNA base A2058) and to phenicols, lincosamides, oxazolidinones, pleuromutilins, streptogramin A, and 16-membered ring macrolides (due to expression of cfr) (55, 56) . The previously described sequences downstream of cfr included half of the istAS gene, which is part of the IS21-558 insertion sequence (56) . Singleprimer PCR was used to sequence the insertion region distal to istAS and to aid in the assembly of orphan contigs from the pyrosequenced genome. As predicted from the sequence of IS21-558, istBS was located adjacent to a complete copy of istAS ( Fig. 2A) . IS21-558 is a novel element, first described in pSCFS6, consisting of the istAS transposase, implicated in replicon fusion, and the istBS helper protein (26) . In CM05, this region begins at nucleotide 5703 with a 57-bp imperfect terminal inverted repeat (26) and ends with a 10-bp truncation of this sequence at nucleotide 8710. The 2,711-bp istAB region (bp 5703 to 8414) in CM05 showed 4-bp and 13-bp mismatches with pSCFS6 and pSCFS3, respectively (26, 28, 29) . The presumptive 1,338-bp istAS gene encodes a 445-amino-acid protein identical to IstAS found in pSCFS3. Overlapping istAS by the last 8 nucleotides, the 753-bp istBS gene encodes a 250-amino-acid protein identical to IstBS in pSCFS3 with the exception of an R169G substitution. It has been proposed that the full-length 46-kDa IstA protein promotes simple transposition events via a "cut-and-paste" mechanism involving circularization of a single copy of IS21 to translocate DNA from the donor to the target site (50) . This process is aided by the 30-kDa IstB helper protein (50) .
The cfr gene and istAB operon are flanked by two large 1,546-bp Tn917-derived repeated elements that include the ermB gene as well as the leader sequence ermL (Fig. 2A) . This second copy of the ermB gene is identical to the ermB gene found in the mlr locus and differs slightly from the ermB gene found in pSM19035 from Streptococcus pyogenes (Ser10 in CM05 versus Asn10 in pSM19035) (10) . Each of these large repeats is flanked by a 63-bp perfect inverted repeat that begins with the sequence 5=-GGGGTCCC-3=. Outside of this region, the proximal 1,546-bp repeat is also flanked by a larger inverted repeat sequence containing the cfrL leader, which may have resulted from a transposition/ recombination event. This large region of duplication is antici- pated to be unstable due to the possibilities of crossing over, resulting in deletion of the intervening region containing cfr, istAS, and istBS along with one of the ermB copies.
Near-perfect identity to pSM19035 resumes at nucleotide 8412 through the end of the insert at nucleotide 15511. This region of homology begins 5= of the ermL leader sequence and ermB, followed by the plasmid addiction system operon, comprising zeta toxin, epsilon antitoxin, and the omega autorepressor/regulator on the complementary strand ( Fig. 2A) . Short 7-bp repeat omega binding site elements are observed immediately upstream of the omega gene and the adjacent delta gene (parA), suggesting autoregulation of the addiction system operon as well as the delta gene. The delta gene encodes an ATPase required for chromosomal partitioning (45) . The end of the insert contains genes encoding the gamma topoisomerase, the ␤/six site-specific recombinase, and the hypothetical alpha gene product, whose function is unknown (10) . The CM05 insert ends with a truncated ␤/six recombinase recognition site (Fig. 2 and 3) . The immediately flanking region contains the 1,667-nucleotide remainder of the 23S rRNA gene, which was precisely split by the insertion of the 15,511-bp element.
It should be noted that the 15.5-kb insertion region does not share significant sequence similarity with the previously characterized 33.7-kb plasmid present in CM05 (GenBank accession no. GQ900387). This suggests that the acquisition and subsequent integration of the cfr-carrying pSM19035-like plasmid occurred independently of the endogenous plasmid in this strain.
Insertion of the cfr region into the CM05 chromosome occurs at a ␤/six site I recognition site. The ␤/six recombinase is known to have a specific recognition sequence (six site) consisting of a 90-bp element that contains two regions (sites I and II) (Fig. 3A) (1). Recombination (Fig. 3B) is catalyzed by the ␤-recombinase and requires two 90-bp ␤/six sites in either a direct or an inverted orientation (9, 48) . Two of these sites are present in pSM19035, a 29-kb broad-host-range plasmid (1, 10) . DNA sequence analysis suggests that the configuration observed in CM05 is likely due to insertion of a pSM19035-like plasmid into the genome, with the recombination event occurring precisely within the site I recognition region (5=-GTATAC-3=), which has previously been shown to be critical for strand exchange (Fig. 3A) (9) . This recombination event would have resulted in the location of a portion of site I at one end of the CM05 insert, with the remainder of the recombination site located at the other end of the 15,511-bp insert (Fig. 3C) . The 23S rRNA insertion site shares little sequence homology with the ␤/six recognition site aside from the nucleotides at the site of insertion (data not shown).
LZD plating discrepancies reveal a subpopulation of cfrnegative CM05 (CM05⌬). A culture derived from a master glycerol stock of CM05 was plated onto MHA plates containing different concentrations of LZD (0.25 to 32 g/ml) or TR-700 (0.25 to 2 g/ml), an expanded-spectrum oxazolidinone whose potency on the MIC level has been shown previously to be unaffected by Cfr methylation (33) . Although the MIC of LZD was 8 g/ml, Ͻ30% of the CFU plated grew on plates containing 2 or 4 g/ml of LZD (Table 2 ). In contrast, TR-700 produced growth inhibition consistent with a MIC of 0.5 g/ml ( Table 2 ).
The differences in plating efficiencies were explored further. Analysis of individual colonies from the glycerol stock plating revealed a mixture of LZD r and LZD s clones. To determine whether the loss of the cfr gene was responsible for the differences in phenotype, 10 colonies were chosen for further study. MIC analysis revealed two distinct populations for which the LZD MIC was either 8 g/ml or 2 g/ml (Table 3) . PCR amplification (cfr_F/ cfr_R) generated the predicted ϳ1-kb cfr PCR product from chromosomal DNA isolated from all 5 of the LZD r colonies; however, no product was obtained from the 5 CM05⌬ LZD s colonies (data not shown).
Strain CM05⌬ arises from recombination between duplicate ermB regions. Comparative analysis of cfr region insertion sequences between individual colonies of strains CM05 and CM05⌬ revealed evidence of a recombination event between the two 1,546-bp repeated ermB (Tn917) elements. In strain CM05, the resulting precise excision of one of the two Tn917 elements, one copy of ermB, and the intervening cfr, istAS, and istBS genes would lead to the generation of 5,987-bp minicircles (Fig. 2B and C) . PCR was performed on a mixed CM05-CM05⌬ total-DNA sample to amplify the minicircles using outward-facing primer sets for istAS and istBS. The PCR bands generated matched the predicted sizes, and follow-up sequencing confirmed that they were indeed specific to the istAS-istBS-ermB-cfr minicircle sequence (data not shown) (Fig. 4) . The primer sets additionally generated smaller bands of ϳ2 kb, which were sequenced and confirmed to contain istAS and istBS in circular form without intervening cfr or ermB genes, suggesting that this region can be excised independently from the greater 15-kb insert to form 2,454-bp minicircles (Fig. 4) . The bridging sequence in these minicircles (istBS downstream sequence, 5=-GCGAAATACA-3=; istAS upstream sequence, 5=-TGT GTATATG-3=) occurs at the imperfect terminal inverted repeats previously identified in the nearly identical 2,446-bp IS21-558 insertion sequence from pSCFS3 (28) .
Nonselective serial passage of CM05 results in a CM05⌬ population of cells possessing the ermB-cfr-istAS-istBS excision/recombination event. To explore the origin and to attempt to recapitulate the recombination event responsible for generating the CM05⌬ strain, nonselective serial passage of a clonal cfr-positive CM05 culture was performed. As a proxy to measure the loss of cfr, the ratio of LZD r to LZD s colonies was monitored every 5th passage in MHB through replica plating of colonies in MHB alone and MHB plus 4 g/ml LZD. The data in Fig. 5 show that the percentage of LZD r cfr-positive colonies in the population decreased as the serial passage number increased. By passage 30, no LZD r colonies were detected through plating (Ͻ1% of the total cell population) (Fig. 5) , and the culture was PCR negative for cfr after 75 passages. LZD s colonies from P75 were confirmed to possess the same deletion of cfr-istAS-istBS-ermB as was documented in the CM05⌬ strain in the initial mixed population (Fig. 2D) .
CM05⌬ possesses a fitness advantage over CM05. To investigate whether the shift of the CM05 culture to a CM05⌬ culture through nonselective passage was due to a high-frequency recom- bination event or to a fitness advantage of CM05⌬ cells over CM05 cells, we compared the growth rates of clonal CM05 and CM05⌬ strains in MHB (Fig. 6 ). These two strains had similar log-phase growth rates and attained the same stationary-phase OD 600 ; however, CM05 exhibited a longer lag phase than CM05⌬. The fitness advantage of CM05⌬ over CM05 likely accounts for the dominance of CM05⌬ under nonselective passage. Passage of a mixed CM05-CM05⌬ population in the presence of LZD selects for cfr maintenance, whereas passage in the presence of TR-700 does not. To further investigate the fitness advantage of CM05⌬ and explore the drug-related selection and maintenance of cfr-positive strains, we performed serial passage experiments with mixed populations of CM05 and CM05⌬ using in vitro passage in the presence of TR-700 or LZD. Because Cfr confers resistance to LZD, the competitive advantage of CM05⌬ was not seen during passage of a mixed CM05-CM05⌬ culture on LZD gradient plates. Thus, the serial-passage population in LZD resulted in cfr-positive colonies as the predominant clonal type (Fig. 7) . Serial passage in the presence of TR-700, however, resulted in a homogeneous CM05⌬ population following 14 serial passages, demonstrating the competitive growth advantage of CM05⌬ even under potentially selective conditions. Previous structure-activity relationship (SAR) studies have shown that the reduced steric hindrance of the A-ring C-5 hydroxymethyl of TR-700, in contrast to the bulkier hydroxymethyl group present on LZD (and other oxazolidinones such as radezolid), accounts for the retention of potency against cfr-positive strains (33) and the concomitant lack of selective pressure to retain cfr. Despite reports of clinical cfr strains possessing multiple classes of 50S mutationbased resistance mechanisms (5, 14, 36) , CM05 under selection with LZD for 30 passages did not generate any cells with enhanced LZD resistance above the starting 8-g/ml level. Whether this is a strain-specific phenomenon or whether it is related to the insertion of the cfr region into the 23S rRNA gene is unknown. The same was true for TR-700; however, the 16-fold-lower mutation frequency of S. aureus with this compound than with LZD could explain the lack of resistance selection, as observed previously with ATCC 29213 (35) .
DISCUSSION
All cfr-positive clinical isolates characterized to date, with the exception of CM05, have possessed a plasmid-borne copy of the gene. Here we have built on the earlier hypothesis that despite the present chromosomal locus of cfr in CM05, its origin is plasmid based (56) . DNA sequence analysis suggests that the complex genetic environment of the cfr gene in CM05 likely arose from a series of transposition and recombination events involving a plasmid with a high degree of sequence similarity to the broad-hostrange plasmid pSM19035 (4) . In addition, plasmids with toxin/ 
FIG 4 PCR amplification of cfr-containing minicircles from CM05⌬ follow-
ing recombination between ermB genes. Outward-facing primer sets encompassing portions of istAS and istBS generated the expected bands for the ϳ6-kb ermB-cfr-istAS-istBS minicircles (larger bands). Additionally, these primers specifically amplified 2.54-kb minicircles containing only the istAS and istBS genes of the IS21-558 insertional element (smaller bands).
FIG 5 Serial passage of CM05 under nonselective conditions. A clonal CM05
cfr-positive culture was serially passaged in MHB 75 times (1:1,000 dilutions). Every 5th passage, the ratio of cfr-positive to cfr-negative colonies was determined. At passage 30, LZD r CM05 cells were no longer detected in the sampling (Ͻ1% of the population). By passage 75, the culture was PCR negative for the cfr gene, suggesting a complete conversion to CM05⌬ LZD s cells.
antitoxin maintenance systems highly similar to that of pSM19035 have been seen in Enterococcus faecium and Enterococcus faecalis (32, 54) . The instability of cfr within this greater chromosomal insertion locus in the absence of selective pressure selects for recombination events whereby the gene is excised and may potentially be transmitted horizontally. Furthermore, the association of the cfr gene with pSM19035 suggests that other strains containing functional cfr-positive versions of the free plasmid may exist, providing another means of horizontal spread of this resistance mechanism into many pathogenic species. The remnants of a recombination event within S. aureus CM05 disrupted a 23S rRNA gene and the pSM19035 ␤/six site and was possibly mediated by the ␤/six recombinase protein. These sequences are found at the chromosomal junctions of the 15.5-kb insertion. The ␤/six recombinase catalyzes resolution or inversion between two tandem or inversely oriented six sites, respectively, or integration if the two sites are on different DNA molecules (8) . The 23S insertion site is only marginally reminiscent of the known ␤/six recombinase recognition site, suggesting that the recombinase may have low selectivity or that some other mechanism was involved in the genomic insertion. Insertion of drug resistance plasmids into rRNA genes has not been reported, and thus, further work is needed to determine what selective pressure or transcriptional advantages may result in these integration events. The fact that the plasmid bearing the cfr gene has been inserted into the very genetic material that encodes the target of its modification warrants further investigation. Earlier reports of CM05 described the Tn917 transposon segment, which contains the ermB promoter, the ermB leader, and the ermB gene followed by the cfr leader and cfr gene, which are constitutively expressed (55, 56) . Between the ermB gene and cfr leader is a possible Tn3-like resolution site (5=-CAGCGAAATTT TTAAATCTAT-3=) (47) followed by a 38-bp Tn917 terminal inverted repeat. These sites are both within a 63-bp repeat that is found in an inverted orientation flanking both copies of the ermB gene. Resolution between the Tn917 repeats, at the potential res site, or anywhere within the duplicated ermB region would result in the deletion of the intervening sequence containing cfr, istAS, and istBS. PCR and sequencing document the presence of minicircles containing the intervening sequence within the cell.
The redundancy of rrn alleles opens the possibility that the copy number of mlr can be increased by gene conversion. Association of mlr with transposon and plasmid elements may further increase the mobility of mlr and its potential for horizontal transfer. However, the spontaneous deletion of cfr and 3= flanking sequences suggests that either the gene or, more likely, the associated genetic elements are deleterious in the absence of antibiotic selection (31) . A recent study reported that a strain expressing an active Cfr protein had a growth rate equivalent to that of an isogenic strain expressing a nonfunctional Cys119Ala mutant Cfr protein, thus demonstrating that Cfr methylation imposes a negligible fitness cost (31), which is supported by the existence of clinical cfr strains possessing co-occurring 23S rRNA (14) , L3 (36), or L4 (5) mutations. The lower fitness of CM05 than of CM05⌬ in MHB may be related to the coexpression of cfr and the ermB methyltransferase genes. Methylation of two key peptidyl transferase center bases has been demonstrated to have detrimental effects that methylation of either one on its own would not have (31) . Alternatively, the structural or functional role of any components of the surrounding genetic material (i.e., istAS, istBS, etc.) or the presence of two ermB methyltransferase genes could also have a negative impact on fitness and should be the subject of further study. SAR and modeling work have revealed that the steric clash between the A2503 carbon 8 methyl group with C-5 acetamide substituents on oxazolidinones, such as LZD and radezolid (RX-1741), leads to increases in the MIC (33) . Consistent with this hypothesis, the MIC of TR-700, which possesses a smaller hydroxymethyl C-5 group, was the same for strains CM05 and CM05⌬. This argument is further supported by in vitro serial passage of a mixed CM05-CM05⌬ population in the presence of TR-700, which resulted in a full conversion to the cfr-negative CM05⌬ strain. Presumably, similar selective pressures would exist in in vivo systems, and drugs such as TR-700, or others not falling within the PhLOPS A resistance phenotype, would not select for the maintenance of cfr.
CM05 was the first reported clinical isolate carrying the cfr methyltransferase gene. Here we have further documented the chromosomal locus of cfr, describing its novel association with a pSM19035-like plasmid and its novel integration into a 23S rRNA allele. Although cfr is not contained within a free plasmid in CM05, it still exists in a highly mobile/unstable region, and the presence of recombination-generated minicircles suggests that cfr may still be horizontally transferable from this strain. The ability of cfr to confer resistance to multiple classes of peptidyl transferase center-targeted antibiotics underscores the need for diligence in the selection of therapeutic strategies in areas with precedents for cfr strain outbreaks.
